Prognostic significance of psoas muscle index in male hepatocellular carcinoma patients treated with immune checkpoint inhibitors and tyrosine kinase inhibitors
N Luo, H Li, Y Luo, P Hu, L Liang, R Zhang… - Human Vaccines & …, 2023 - Taylor & Francis
Currently, the relationship between nutritional indices and the prognosis of hepatocellular
carcinoma (HCC) patients treated with immune checkpoint inhibitors (ICIs) and tyrosine …
carcinoma (HCC) patients treated with immune checkpoint inhibitors (ICIs) and tyrosine …
Stabilization of MCL-1 by E3 ligase TRAF4 confers radioresistance
M Li, F Gao, X Li, Y Gan, S Han, X Yu, H Liu… - Cell Death & Disease, 2022 - nature.com
The E3 ligase TNF receptor-associated factor 4 (TRAF4) is frequently overexpressed and
closely related to poor prognosis in human malignancies. However, its effect on …
closely related to poor prognosis in human malignancies. However, its effect on …
Identification of Potential Predictors of Prognosis and Sorafenib-Associated Survival Benefits in Patients with Hepatocellular Carcinoma after Transcatheter Arterial …
K He, Z Yang, X Liu, Y Yang, W Song, S Wang… - Current …, 2022 - mdpi.com
Some studies have shown that sorafenib could significantly prolong the overall survival of
patients with unresectable hepatocellular carcinoma treated with transcatheter arterial …
patients with unresectable hepatocellular carcinoma treated with transcatheter arterial …
